Literature DB >> 34228913

Identification of Secondary Binding Sites on Protein Surfaces for Rational Elaboration of Synthetic Protein Mimics.

Justin M Torner1, Yuwei Yang1, David Rooklin1, Yingkai Zhang1, Paramjit S Arora1.   

Abstract

Minimal mimics of protein conformations provide rationally designed ligands to modulate protein function. The advantage of minimal mimics is that they can be chemically synthesized and coaxed to be proteolytically resistant; a key disadvantage is that minimization of the protein binding epitope may be associated with loss of affinity and specificity. Several approaches to overcome this challenge may be envisioned, including deployment of covalent warheads and use of nonnatural residues to improve contacts with the binding surface. Herein, we describe our computational and experimental efforts to enhance the minimal protein mimics with fragments that can contact undiscovered binding pockets on Mdm2 and MdmX-two well-studied protein partners of p53.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34228913      PMCID: PMC8344045          DOI: 10.1021/acschembio.1c00418

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   4.634


  34 in total

1.  Bent Into Shape: Folded Peptides to Mimic Protein Structure and Modulate Protein Function.

Authors:  Haley I Merritt; Nicholas Sawyer; Paramjit S Arora
Journal:  Pept Sci (Hoboken)       Date:  2020-01-02

2.  Mdm2 and MdmX as Regulators of Gene Expression.

Authors:  Lynn Biderman; James L Manley; Carol Prives
Journal:  Genes Cancer       Date:  2012-03

Review 3.  Structure-based inhibition of protein-protein interactions.

Authors:  Andrew M Watkins; Paramjit S Arora
Journal:  Eur J Med Chem       Date:  2014-09-16       Impact factor: 6.514

4.  Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.

Authors:  P H Kussie; S Gorina; V Marechal; B Elenbaas; J Moreau; A J Levine; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

5.  Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.

Authors:  Baoli Hu; Daniele M Gilkes; Jiandong Chen
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

6.  Identification and characterization of the first small molecule inhibitor of MDMX.

Authors:  Damon Reed; Ying Shen; Anang A Shelat; Leggy A Arnold; Antonio M Ferreira; Fangyi Zhu; Nicholas Mills; David C Smithson; Catherine A Regni; Donald Bashford; Samantha A Cicero; Brenda A Schulman; Aart G Jochemsen; R Kiplin Guy; Michael A Dyer
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

Review 7.  Systematic Targeting of Protein-Protein Interactions.

Authors:  Ashley E Modell; Sarah L Blosser; Paramjit S Arora
Journal:  Trends Pharmacol Sci       Date:  2016-06-04       Impact factor: 14.819

8.  A hydrogen bond surrogate approach for stabilization of short peptide sequences in alpha-helical conformation.

Authors:  Anupam Patgiri; Andrea L Jochim; Paramjit S Arora
Journal:  Acc Chem Res       Date:  2008-07-17       Impact factor: 22.384

9.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

10.  Modulation of virus-induced NF-κB signaling by NEMO coiled coil mimics.

Authors:  Jouliana Sadek; Michael G Wuo; David Rooklin; Arthur Hauenstein; Seong Ho Hong; Archana Gautam; Hao Wu; Yingkai Zhang; Ethel Cesarman; Paramjit S Arora
Journal:  Nat Commun       Date:  2020-04-14       Impact factor: 14.919

View more
  1 in total

1.  Peptide Tethering: Pocket-Directed Fragment Screening for Peptidomimetic Inhibitor Discovery.

Authors:  Ashley E Modell; Frank Marrone; Nihar R Panigrahi; Yingkai Zhang; Paramjit S Arora
Journal:  J Am Chem Soc       Date:  2022-01-14       Impact factor: 15.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.